PUBLICATIONS & CASE STUDIES

 

Since its FDA approval in May 2007, the Mynx Vascular Closure Device has been published in numerous clinical and business journals. Included below are some of these published articles.

 

Note: Access Closure, Inc. is not responsible for the content presented in the following articles and website links.

 

Occurrence of angiographic femoral artery complications after vascular closure with Mynx and AngioSeal
Fargen KM, Velat GJ, Lawson MF, et al. J Neurointerv Surg. 2013;5(2):161-4

 

A Prospective Randomized Single-blind trial of Patient Comfort Following Vessel Closure
Extravascular Synthetic Sealant Closure Provides Less Pain than a Self-tightening Suture Vascular Compression Device.
Kyle M Fargen, MD et al. Journal of NeuroInterventional Surgery. Published Online First January2011

 

Successful Reduction of Surgeries Secondary to Arterial Access Site Complications

A Retrospective Review at a Single-Center with an Extravascular Closure Device.
Sonya Noor, MD et al. Vascular and Endovascular Surgery. 2010*

 

Two Years of Extravascular Closure With the Mynx® Vascular Closure Device

The Baptist Memorial Hospital experience revisited

David Wolford, MD, FACC. Endovascular Today. August 2010

 

Mynx Closure in a Patient Treated for Chronic Total Occlusion of the Iliac Artery with Multiple Sheath Exchanges

A Case Review

Michael S. Fenster, MD. TCTMD. May 2009.

 

Patient Comfort and Patient Satisfaction with the Mynx® Vascular Closure Device

A Single-Center Evaluation

John Byron Patterson, MD. Cath Lab Digest. October 2009.

 

Why Extravascular Closure?

The Baptist Memorial Hospital Experience with the Mynx Vascular Closure Device

David Wolford, MD, FACC. Endovascular Today. August 2009.

 

The Mynx® Vascular Closure Device

Adopting Extravascular Closure Technology in the Catheterization Lab

Ameer Kabour, MD, FACC, FSCAI. Endovascular Today. May 2009.

 

The Mynx Vascular Closure Device:

The Piedmont Heart Institute Experience

Charles L. Brown III, MD, FACC, FACP. Cath Lab Digest. February 2009.

 

Lack of Scarring and Inflammation Observed During Endovascular Repair of an Abdominal Aortic Aneurysm (AAA)

Results 27 Days Following Use of the Mynx Vascular Closure Device

Nishit Choksi, MD. TCTMD, May 2008.

 

The Mynx™ Vascular Closure Device

Initial clinical experience using a novel approach to vascular closure

Gary M. Ansel, MD and Joseph M. Garasic, MD.  Endovascular Today.  January 2008.*

 

The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Vascular Closure

Initial Clinical Results for Mynx™

D. Scheinert MD et al. Catheterization and Cardiovascular Interventions. November 2007.

a

 

Research on Vascular Closure Devices

 

Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing PCI

A Research Study

Stephen P. Marso, MD et al. JAMA 2010;303(21):2156-2164.

 


Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in ACS

Results from the ACUITY Trial

Timothy A. Sanborn, MD et al. Circ Cardovasc Interv. 2010;3:57-62

 

*One or more authors of this article holds a financial ownership in AccessClosure. For more details, please contact the company.

mynx
mynx
mynx
mynx